Rekombinanter Bevacizumab Antikörper

Produktnummer ABIN7482170

Der Maus Monoklonal Anti-Bevacizumab Antikörper wurde für validiert. Er ist geeignet, Bevacizumab in Proben von Human zu detektieren.

Kurzübersicht für Rekombinanter Bevacizumab Antikörper (ABIN7482170)

Target: Bevacizumab

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser Bevacizumab Antikörper ist unkonjugiert

Güteklasse: MALS verified

Klon: AY10

Produktdetails anti-Bevacizumab Antikörper

Verwendungszweck: Anti-Bevacizumab Antibody (AY10) (MALS verified, recommended for PK/PD)

Produktmerkmale: Anti-idiotypic Antibodies

Immunogen: Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Bevacizumab F(ab')2.

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Lagerung: -20 °C

Details zu Bevacizumab

Target: Bevacizumab

Substanzklasse: Antibody

Hintergrund: A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.